Navigation Links
DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares
Date:6/4/2009

solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA, faster and more efficiently than manual methods or loosely integrated technologies. DATATRAK's eClinical software suite can be deployed worldwide through an ASP offering or in a licensed Enterprise Transfer model that fully empowers its clients. The DATATRAK software suite and its earlier versions have successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK International, Inc.'s product suite has been utilized in some aspect of the clinical development of 16 drugs and one medical device that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio, and Bryan, Texas. Visit the DATATRAK International, Inc. web site at www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. Factors that may cause actual results to differ materially from those in the forward-looking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhanc
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007
2. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
3. DATATRAK International Launches Innovative, Interactive Educational Webcast Series
4. DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference
5. DATATRAK Closes Second Multi-Year Enterprise Agreement with European Clinical Trial Sponsor
6. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007
7. DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
8. DATATRAK Announces Restructured Senior Management Team
9. Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies
10. DATATRAK International, Inc. Receives Notice From Nasdaq
11. DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... HAPPYneuron,s most popular an...the iPhone and iPod Touch. , ... HAPPYneuron,s most popular and addictive game, Sp...Touch. Split Words is designed to help banish that...litWords iPhone brain game challenges the brain ...
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understandi.... 20 Dr. Jeremy Schmahm...ool and neurologist at the Massachusetts General H...nted his laboratory,s research on the new field of...MINDlink Foundation. ,, Dr. Schmahmann is an aw...
(Date:11/20/2009)... , QUINCY, Mass., Nov. 20 Follo...rmarket Company removed from sale Shedd,s Country ...ice and Shedd,s Country Crock ® Side Dishes D...te allergen. ,, The following code dates and U...74; Side Dishes DELUXE Cheddar Broccoli Rice 21 oz...
(Date:11/20/2009)... , ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/...ounced that it will present at the Bank of America...December 2-3, 2009, at the Crowne Plaza Hotel Time...ent Wednesday, December 2nd at 8:30 a.m. Eastern T...cess a live, audio webcast of Centene,s presentati...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCall...unced that it will broadcast Doctor Radio Repor...s , an in-depth special hosted by veteran journali...com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Doc...w About Mammograms will air November 21 live at...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...for the development of muscles.Da-Zhi Wang and oth... at Chapel Hill // said that the genes are among a... worm 12 years ago. Only in the past few years...appeared in the latest online edition of the journ...
...ni pharmaceutical companies are keen to enhance bu...nment // to relax the stringent visa norms. Pa...and raw materials provided by the Chinese, apart f...sman for the Pakistan Pharmaceutical Manufacturers...
... Research Center has reported that maintaining the...reduce the risk // of cardiovascular disease. The...he blood glucose level of their patients less than...the last few months, the test measures the amount ...
...ed in his recent article that having induced abort...Dr. Brind has compiled data from recent studies of...rnal of American Physicians and Surgeons. Pr...ncrease the risk of developing breast cancer and e...
... increased risk of developing eye problems. A revi...and Zohar Habot-Wilner // , Goldschleger Eye Insti... reviews and found that risk of developing eye pro... found that obese people have high risk of develop...
...l can do to people. High-fat diets cause many pati...g at food labels // to know what they consume. ...r for consumers to avoid trans fats, which plug ar...o vegetable oils to improve shelf life. If a produ...
Other Medicine News:Health News:Pakistan drug companies seek trade ties with India 2Health News:Food labels to include information on trans fats in US 2Health News:Food labels to include information on trans fats in US 3
(Date:11/20/2009)...ire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ...ief Executive Officer, and Greg Browne, Chief Fina...er Jaffray Health Care Conference in New York on W...onference session and webcast will be audio only a...ray will host a webcast of the presentation live a...
(Date:11/20/2009)...0 BD (Becton, Dickinson ...mpletion of its acquisition of HandyLab, Inc., an ...d manufactures molecular diagnostic assays and aut...Lab announced an exclusive agreement for BD to dev...dyLab Jaguar(TM) platform, the first fully integra...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bull...erly known as DOR BioPharma, Inc., a late-stage bi...ormed a consortium to develop thermostable technol...vaccines. Soligenix received a $9.4 million grant ...ous Diseases (NIAID), a division of the National I...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 1Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 1Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 2Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 3Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 4Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 5Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara 28R 29 for the Treatment of Brain Cancer 12651 6Torn Surgical Gloves Put Patients at Risk for Infection 49069 1Torn Surgical Gloves Put Patients at Risk for Infection 49069 2
...t fails to mention ongoing FDA-approved HIFU clini...nical data on HIFU outcomes and experience, CHARL...stributor of the minimally invasive Sonablate(R) 5...h America, announced that the June 16, 2008,editio... intensity focused,ultrasound (HIFU) for treating ...
...ubmission Based on Data from Placebo-Controlled Ph...tients in a Randomized Study, WOODCLIFF LAKE, N.J...ounced today that the U.S. Food and Drug Administr...plemental biologics license,application (sBLA) for...d,approval indication into full approval. It is ba...
Other Medicine Technology:ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 2ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 2FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 4FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 5
...Drug Screen Tests are available in 14 configuratio...Designed using Microgenics Antibody Technology, th...point of care immunoassay targeted to detect MDMA ...cross-reactivity to any isomer of methamphetamine ...
...ite test! QuickScreen™ multi-panel dip cards...our choice of any conceivable combination of 9 dif...r total flexibility for your drug testing program....-in timer tells you when to read the results. Our ...
Insure
...tely 500,000 people die each year of colon cancer ...mprovements (high contrast berium enema, colonosco...e in the success rate of curative treatment for co... past two decades. The chances of successful treat...
Medicine Products: